rs747478031
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001099922.3(ALG13):āc.1304A>Gā(p.Asn435Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,186,141 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001099922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG13 | NM_001099922.3 | c.1304A>G | p.Asn435Ser | missense_variant | 11/27 | ENST00000394780.8 | NP_001093392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG13 | ENST00000394780.8 | c.1304A>G | p.Asn435Ser | missense_variant | 11/27 | 2 | NM_001099922.3 | ENSP00000378260 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000446 AC: 5AN: 112009Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34149
GnomAD3 exomes AF: 0.000207 AC: 31AN: 149947Hom.: 0 AF XY: 0.000113 AC XY: 5AN XY: 44079
GnomAD4 exome AF: 0.0000419 AC: 45AN: 1074080Hom.: 0 Cov.: 26 AF XY: 0.0000233 AC XY: 8AN XY: 343352
GnomAD4 genome AF: 0.0000446 AC: 5AN: 112061Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34211
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 22, 2016 | A variant of uncertain significance has been identified in the ALG13 gene. The N435S variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The N435S variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. However, this variant was not observed in approximately 5,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Developmental and epileptic encephalopathy, 36 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at